C B PHARMA ACQUISITION CORP's ticker is CNLM and the CUSIP is G2029P126. A total of 8 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,555,000 | +1.5% | 550,000 | 0.0% | 0.24% | -17.5% |
| Q4 2015 | $5,472,000 | -0.1% | 550,000 | 0.0% | 0.28% | -13.6% |
| Q3 2015 | $5,475,000 | +0.8% | 550,000 | 0.0% | 0.33% | +39.8% |
| Q2 2015 | $5,434,000 | +0.9% | 550,000 | 0.0% | 0.24% | -19.7% |
| Q1 2015 | $5,387,000 | – | 550,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weiss Asset Management LP | 423,246 | $4,275,000 | 1.06% |
| Polar Asset Management Partners Inc. | 550,000 | $5,555,000 | 0.24% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,535,000 | 0.08% |
| Karpus Management, Inc. | 131,601 | $1,329,000 | 0.06% |
| AQR Arbitrage LLC | 350,000 | $3,535,000 | 0.04% |
| Yakira Capital Management, Inc. | 12,500 | $126,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 303 | $3,000 | 0.00% |
| MORGAN STANLEY | 9 | $0 | 0.00% |